Trial intelligence / Profile preview

Dexamethasone and edaravone for lung protection during one-lung ventilation

ChiCTR2600117649Phase 4Not yet recruiting

Sponsor
The Second Affiliated Hospital of Xi'an Jiaotong University
Start
Jan 2026
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexamethasone and edaravone in not applicable; "lung injury" is not a specific disease (4 arms), sponsored by The Second Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Postoperative pulmonary complications within 7 days. Planned start Jan 2026; status: not yet recruiting.

02

Drugs

dexamethasoneedaravone
03

Conditions

not applicable; "lung injury" is not a specific disease

Beyond the preview

Go deeper on ChiCTR2600117649.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600117649.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call